Pandemic Analysis V: The Science and Economics of a Vaccine for Ending the Pandemic

S. Niggol Seo

Chapter Chapter 7 in The Economics of Pandemics, 2022, pp 199-232 from Springer

Abstract: Abstract This chapter provides, after a comprehensive review of the COVID-19 vaccine development and administration efforts during 2020 and 2021, an exposition of economic and policy questions on pandemic vaccines. It starts with the science of vaccines or vaccinology explained in the context of the novel coronavirus. A list of historical achievements in vaccinology is reviewed. For the COVID-19, the vaccine development process comprised a selection of vaccine methodologies, a candidate vaccine manufacturing, a selection of candidate vaccines, three phases of clinical trials, an emergency use authorization, a mass production, and a mass distribution. A critical role that the government has played in developing high-efficacy mRNA vaccines in record time can be explained by the Operation Warp Speed. Six unique aspects of the vaccine economics are clarified: inter alia, an incredible benefit-cost ratio, a backstop technology solution, a time lapse between the pandemic outbreak and the first vaccine availability, a best-shot production technology. These are referred to in this chapter as the four dimensions of the vaccine economics. Finally, this chapter provides an early analysis of whether the worldwide vaccination efforts will end the COVID-19 and whether the country vaccination rates will reach a plateau soon.

Keywords: Vaccine; Coronavirus; Antibody; Operation Warp Speed; Clinical Trials; Emergency Use Authorization; Backstop; Time Lapse; Best-shot; Vaccination Rate; Pfizer; Moderna; mRNA vaccines; B & T Cells (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-91021-1_7

Ordering information: This item can be ordered from
http://www.springer.com/9783030910211

DOI: 10.1007/978-3-030-91021-1_7

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().